MX2023014468A - Vacuna contra el coronavirus a base de particulas similares al virus. - Google Patents

Vacuna contra el coronavirus a base de particulas similares al virus.

Info

Publication number
MX2023014468A
MX2023014468A MX2023014468A MX2023014468A MX2023014468A MX 2023014468 A MX2023014468 A MX 2023014468A MX 2023014468 A MX2023014468 A MX 2023014468A MX 2023014468 A MX2023014468 A MX 2023014468A MX 2023014468 A MX2023014468 A MX 2023014468A
Authority
MX
Mexico
Prior art keywords
coronavirus
virus
cov
particle vaccine
sars
Prior art date
Application number
MX2023014468A
Other languages
English (en)
Spanish (es)
Inventor
Charles Richardson
Niranjan Kanesa-Thasan
Original Assignee
Icosavax Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Icosavax Inc filed Critical Icosavax Inc
Publication of MX2023014468A publication Critical patent/MX2023014468A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/215—Coronaviridae, e.g. avian infectious bronchitis virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0258—Escherichia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5258—Virus-like particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55561—CpG containing adjuvants; Oligonucleotide containing adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • A61K2039/575—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2 humoral response
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6068—Other bacterial proteins, e.g. OMP
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/20011—Coronaviridae
    • C12N2770/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
MX2023014468A 2021-06-07 2022-06-03 Vacuna contra el coronavirus a base de particulas similares al virus. MX2023014468A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202163197952P 2021-06-07 2021-06-07
PCT/US2022/032201 WO2022260960A1 (en) 2021-06-07 2022-06-03 Virus-like particle vaccine for coronavirus

Publications (1)

Publication Number Publication Date
MX2023014468A true MX2023014468A (es) 2024-01-17

Family

ID=84425412

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2023014468A MX2023014468A (es) 2021-06-07 2022-06-03 Vacuna contra el coronavirus a base de particulas similares al virus.

Country Status (10)

Country Link
US (1) US20240252621A1 (OSRAM)
EP (1) EP4351638A4 (OSRAM)
JP (1) JP2024520730A (OSRAM)
KR (1) KR20240019213A (OSRAM)
CN (1) CN118159288A (OSRAM)
AU (1) AU2022289462A1 (OSRAM)
CA (1) CA3221041A1 (OSRAM)
IL (1) IL308842A (OSRAM)
MX (1) MX2023014468A (OSRAM)
WO (1) WO2022260960A1 (OSRAM)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW202500574A (zh) * 2023-05-12 2025-01-01 美商伊科薩瓦克斯有限公司 冠狀病毒刺突醣蛋白受體結合域及其用途
CN121758566A (zh) * 2023-11-03 2026-03-31 广东蓝玉生物科技有限公司 非洲猪瘟病毒e248r蛋白的免疫原性组合物及其应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2535421T3 (es) * 2011-03-22 2015-05-11 Mucosis B.V. Composiciones inmunogénicas en forma particulada y métodos para producir las mismas
CN112521511B (zh) * 2020-12-07 2023-03-14 中山大学 一种含EB病毒gB蛋白的自组装纳米颗粒及其制备方法与应用

Also Published As

Publication number Publication date
EP4351638A1 (en) 2024-04-17
WO2022260960A1 (en) 2022-12-15
CN118159288A (zh) 2024-06-07
IL308842A (en) 2024-01-01
AU2022289462A1 (en) 2023-12-14
EP4351638A4 (en) 2025-05-14
CA3221041A1 (en) 2022-12-15
AU2022289462A9 (en) 2024-01-04
KR20240019213A (ko) 2024-02-14
US20240252621A1 (en) 2024-08-01
JP2024520730A (ja) 2024-05-24

Similar Documents

Publication Publication Date Title
WO2022155530A8 (en) Variant strain-based coronavirus vaccines
MX2021006342A (es) Mutantes de virus de influenza y usos para los mismos.
WO2010019262A3 (en) Polyvalent vaccine
MX2021000285A (es) Composiciones que comprenden cepas bacterianas.
MX346245B (es) Proteina de fusion que comprende el mutante crm197 no toxico de toxina de difteria.
WO2021154812A8 (en) Coronavirus vaccine formulations
WO2015142671A3 (en) Influenza virus vectors and uses therefor
MX2018015506A (es) Vacuna contra virus de bronquitis infecciosa.
MX2023006203A (es) Vacunas novedosas contra el virus de zika.
BR112013011194A2 (pt) partículas de glicoproteína semelhantes a vírus (vlps) da raiva.
EP4691484A3 (en) Influenza mrna vaccines
EP3725328A3 (en) Novel adjuvant compositions
BR112016007919A2 (pt) vacinas atenuadas vivas
WO2019090233A3 (en) Method for inactivating zika virus and for determining the completeness of inactivation
BR112012019637A2 (pt) método de indução de anticorpos neutralizantes contra quatro sorotipos da febre da dengue, vírus da caxumba, vírus do sarampo e rubéola em um mamífero, kit de imunização e uso de vírus vacinais tetravalentes da dengue e trivalentes de mmr para a fabricação de uma vacina para a imunização
NZ715459A (en) A hyperbarically-inactivated microorganism, immunogenic compositions comprising same and methods for producing same
WO2022204713A3 (en) Antibodies to sars-cov-2
MX2024003337A (es) Composiciones inmunogenicas contra la influenza.
NZ591188A (en) West nile virus vaccine
WO2013173256A3 (en) New and improved influenza vaccines
WO2022261297A3 (en) Broadly reactive viral antigens as immunogens, compositions and methods of use thereof
MX2023011129A (es) Mutantes del virus de la influenza b y usos de los mismos.
WO2023067193A3 (en) Compositions for administration of different doses of rna
MX2018009048A (es) Extracto de streptococcus uberis como agente inmunogenico.
WO2019075300A3 (en) Mayaro virus consensus antigens, dna antibody constructs for use against mayaro virus, and combinations thereof